Lv41
540 积分 2022-11-10 加入
Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases
5天前
已完结
Predictors of Response to Topical Ruxolitinib in Non‐segmental Vitiligo: A Narrative Review
14天前
已完结
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis
20天前
已完结
Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo
1个月前
已完结
The immunology of vitiligo
2个月前
已完结
The Hospital Anxiety and Depression Scale
2个月前
已完结
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
2个月前
已完结
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
2个月前
已完结
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
2个月前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
2个月前
已完结
皖公网安备34019202002308
